Glucagon: all 79 studies that test it
Page 1 of 1. Open to participants first (5), then studies with results posted, then the rest; newest registration first within each.
- Post-Prandial Carbohydrate Metabolism in Individuals With and Without Post-Bariatric Surgery Hypoglycemia (PBH)RecruitingNCT07818707Phase 4
- The Postprandial Hypo-Avoid StudyRecruitingNCT07427251Phase 4
- Studies of Insulin and Glucagon Action in the LiverNot yet recruitingNCT07300982Phase 1/2
- The Effects of Glucagon on Renal Regional Blood Flow in Humans Measured by Magnetic Resonance.Not yet recruitingNCT06872060Not applicable
- Human Models of Selective Insulin Resistance: Pancreatic ClampNot yet recruitingNCT06558422Phase 1
- The Effects of Glucagon on Hepatic MetabolismCompletedNCT05500586Phase 1/2Results posted
- Glucagon and Advanced HCL System to Prevent Exercise-Induced Hypoglycaemia in People With Type 1 DiabetesCompletedNCT05379686Not applicableResults posted
- A Study of Nasal Glucagon (LY900018) in Pediatric Participants With Type 1 DiabetesCompletedNCT04992312Phase 1Results posted
- The Effect of Glucagon on Rates of Hepatic Mitochondrial Oxidation in Man Assessed by PINTACompletedNCT03965130Phase 1Results posted
- G-Pen Compared to Glucagen Hypokit for Severe Hypoglycemia Rescue in Adults With Type 1 DiabetesCompletedNCT03738865Phase 3Results posted
- Glucagon Infusion in T1D Patients With Recurrent Severe Hypoglycemia: Effects on Counter-Regulatory ResponsesTerminatedNCT03490942Phase 2Results posted
- G-Pen™ Compared to Lilly Glucagon for Hypoglycemia Rescue in Adults With Type 1 DiabetesCompletedNCT03439072Phase 3Results posted
- A Study of Nasal Glucagon (LY900018) in Japanese Participants With Diabetes MellitusCompletedNCT03421379Phase 3Results posted
- A Study of Nasal Glucagon in Participants With Type 1 Diabetes MellitusCompletedNCT03339453Phase 1Results posted
- Closed-Loop Glucagon Pump for Treatment of Post-Bariatric HypoglycemiaCompletedNCT03255629Phase 1/2Results posted
- Efficacy of Glucagon In the Prevention of Hypoglycemia During Mild ExerciseTerminatedNCT03217175Not applicableResults posted
- A Trial to Evaluate the Immunogenicity of Dasiglucagon and GlucaGen in Patients With Type 1 Diabetes MellitusCompletedNCT03216226Phase 3Results posted
- Glucose Response of G-Pen (Glucagon Injection) in Pediatric T1D PatientsCompletedNCT03091673Phase 3Results posted
- CSI-Glucagon for Prevention of Hypoglycemia in Children With Congenital HyperinsulinismCompletedNCT02937558Phase 2Results posted
- A Study of Single or Repeated Doses of Glucagon in Participants With DiabetesCompletedNCT02806973Phase 1Results posted
- A Study of Single and Repeated Doses of Glucagon Administered to Participants With DiabetesTerminatedNCT02806960Phase 1Results posted
- A Study of Glucagon Administered in Different Forms and Routes to Healthy AdultsCompletedNCT02778113Phase 1Results posted
- Delivery of G-Pump™ (Glucagon Infusion) From an OmniPod® to Prevent Hypoglycemia in Post-Bariatric Surgery PatientsCompletedNCT02733588Phase 2Results posted
- The iLet Introduction Study: A Feasibility Study of the iLet, a Fully Integrated Bihormonal Bionic PancreasTerminatedNCT02701257Not applicableResults posted
- Safety and Efficacy of G-Pen Compared to Lilly Glucagon for Hypoglycemia Rescue in Adult Type 1 DiabeticsCompletedNCT02656069Phase 3Results posted
- G-Pen™ for Hypoglycemia Rescue in T1D PatientsCompletedNCT02423980Phase 2Results posted
- Clinical Usability of Nasal Glucagon in Treatment of Hypoglycemia in Children and AdolescentsCompletedNCT02402933Phase 3Results posted
- Clinical Usability of Intranasal Glucagon in Treatment of HypoglycemiaCompletedNCT02171130Phase 3Results posted
- Glucagon Use in ColonoscopiesCompletedNCT02078726Phase 4Results posted
- Assessment of Intranasal Glucagon in Children and Adolescents With Type 1 DiabetesCompletedNCT01997411Phase 2/3Results posted
- Efficacy and Safety of Nasal Glucagon for Treatment of Hypoglycemia in AdultsCompletedNCT01994746Phase 3Results posted
- Safety Study of Repeated Doses of Glucagon on Animal Starch in the LiverCompletedNCT01986231Not applicableResults posted
- Evaluate the Immunogenicity of a Novel Glucagon FormulationCompletedNCT01959334Phase 3Results posted
- Safety and Efficacy of a Novel Glucagon Formulation in Type 1 Diabetic Patients Following Insulin-induced HypoglycemiaCompletedNCT01556594Phase 2Results posted
- Physiologic Response to Glucagon at Varying Insulin LevelsCompletedNCT01483651Not applicableResults posted
- Sensor-Augmented Insulin Delivery: Insulin Plus Glucagon Versus Insulin AloneCompletedNCT00797823Phase 2Results posted
- Measuring Amino Acid and Glucose Metabolism in Healthy Volunteers and NAFLD Patients Using Total-body PETActive, not recruitingNCT07366710Not applicable
- Glucagon Dose-Response in Patients With Post-Bariatric HypoglycemiaActive, not recruitingNCT06986603Phase 4
- Research Study in Japan to Compare Dasiglucagon With Glucagon in Treating Very Low Levels of Blood Sugar in Asian Adults With Type 1 Diabetes and Testing of Dasiglucagon for the Same Condition in Japanese AdolescentsCompletedNCT06588504Phase 1
- Glucagon Enhanced Insulin Absorption in Diabetes Mellitus Type 1TerminatedNCT05960565Phase 2
- Pancreatic Clamp in NAFLDCompletedNCT05724134Phase 1
- Stimulation Test With Intranasal Glucagon for Corticotroph, Somatotroph and Antidiuretic AxesCompletedNCT05206149Phase 4
- Low-dose Glucagon for Prevention of Exercise-Induced Hypoglycemia in People With Type 1 DiabetesCompletedNCT05076292Not applicable
- The Role of the Kidneys and Liver in the Elimination of GlucagonCompletedNCT05056584Not applicable
- Dual-Hormone Closed-Loop Glucose Control in Adolescents With Type 1 DiabetesCompletedNCT04949867Phase 4
- The Effect of Lifestyle-induced Hepatic Steatosis on Glucagon-stimulated Amino Acid TurnoverCompletedNCT04859322Not applicable
- A Trial to Investigate Hyperglycemic and Hypoglycemic Excursions in Subjects With Type 1 DiabetesCompletedNCT04712266Early Phase 1
- Glucagon Regulation of Glucose MetabolismCompletedNCT04347252Phase 1
- Effect of Physiologic Hyperglucogonemia on Adipocyte MetabolismCompletedNCT04300049Early Phase 1
- Dual-hormone Closed-loop Glucose Control in Type 1 DiabetesCompletedNCT04053712Phase 4
- Mini-Dose Glucagon to Treat Fasting-induced Hypoglycemia During RamadanCompletedNCT03970772Not applicable
- Haemodynamic Effects of GLP-1 and Glucagon in Healthy Male VolunteersCompletedNCT03835013Not applicable
- Glucagon Ready to Use (RTU) in Subjects With Hyperinsulinemic Hypoglycemia After Bariatric SurgeryCompletedNCT03770637Phase 2
- Intranasal Glucagon and Energy BalanceStatus unknownNCT03650582Phase 2/3
- Glucagon's Cardiovascular Effects With and Without Beta-blocker-induced CardioinhibitionCompletedNCT03533179Phase 4
- Hepatic Metabolic Changes in Response to Glucagon InfusionCompletedNCT03526445Not applicable
- Effect of Prolonged (72 Hour) Glucagon Administration on Energy Expenditure in Healthy Obese SubjectsActive, not recruitingNCT03139305Phase 1
- Characterization of Metabolic and Brain Effects of Rising Glucagon During an Oral Glucose ChallengeCompletedNCT03061227Not applicable
- Closed-loop Control of Glucose Levels (Artificial Pancreas) for 15 Weeks in Adolescents and Adults With Type 1 DiabetesWithdrawnNCT02846857Phase 2
- To Determine Tolerability to Glucagon Infusion in Obese SubjectsActive, not recruitingNCT02817659Phase 1
- In Vivo Assessment of Cellular Metabolism in HumansCompletedNCT02748369Phase 1
- Assessment of Intranasal Glucagon on Endogenous Glucose ProductionCompletedNCT02740829Phase 1
- Closed-loop Control of Postprandial Glucose Levels in Children and Adults With Type 1 DiabetesWithdrawnNCT02490098Phase 2
- Hyperglucagonaemia in Patients With Type 2 Diabetes - Role of Glucagon ClearanceCompletedNCT02475421Not applicable
- Safety and Efficacy of ZP-Glucagon to Injectable Glucagon for HypoglycemiaCompletedNCT02459938Phase 1
- Closed-loop Control of Postprandial Glucose Levels in Adults With Type 1 DiabetesCompletedNCT02416765Phase 2
- Treatment of Low Blood Sugar With Glucagon Among Patients With Type 1 DiabetesStatus unknownNCT02232971Phase 4
- Bioequivalence of Fresenius Kabi USA, LLC Glucagon for SC Injection Compared to Glucagon for Injection (Bedford Laboratories)CompletedNCT02086227Phase 1
- Trial to Compare the Relative Pharmacodynamic Properties of Different Glucagon DosagesCompletedNCT01916265Phase 1
- Efficacy of Small Subcutaneous Glucagon Dose to Treat Hypoglycemia in Adults With Type 1 DiabetesWithdrawnNCT01828125Phase 2
- Study of Glucagon, Ghrelin and Growth Hormone as Counterregulatory HormonesStatus unknownNCT01795235Not applicable
- Effect of Glucagon on Uterine Contractility at the Time of Embryo Transfer in in Vitro FertilizationWithdrawnNCT01674283Phase 4
- Acute Regulation of Intestinal and Hepatic Lipoprotein Production by GlucagonCompletedNCT01155206Phase 4
- Glucagon Modulation of Ghrelin SecretionStatus unknownNCT00929812Phase 3
- A Phase 1 Study to Evaluate the Safety and Tolerability of GSK1362885 in Healthy Normal SubjectsCompletedNCT00823940Phase 1
- To Evaluate the Response to Glucagon During HypoglycemiaCompletedNCT00817271Phase 1
- Glucagon in the Treatment of Hypoglycemia in Newborn Infants of Diabetic MothersCompletedNCT00434772Phase 2
- The Role of Amylin and Glucagon in T1DMCompletedNCT00206258Phase 3
- Intravenous-Morphine and Glucagon-Usage Enhanced MR CholangiographyStatus unknownNCT00155376Phase 4